Major Estimate Revision • May 04
Consensus EPS estimates fall by 25% The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate fell from CN¥1.20 to CN¥0.906 per share. Revenue forecast steady at CN¥29.0b. Net income forecast to grow 178% next year vs 58% growth forecast for Chemicals industry in China. Consensus price target down from CN¥23.03 to CN¥22.31. Share price fell 5.0% to CN¥16.91 over the past week. Reported Earnings • Apr 28
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: EPS: CN¥0.52 (down from CN¥0.91 in FY 2024). Revenue: CN¥26.0b (down 5.5% from FY 2024). Net income: CN¥1.24b (down 43% from FY 2024). Profit margin: 4.8% (down from 7.9% in FY 2024). Revenue missed analyst estimates by 1.9%. Earnings per share (EPS) also missed analyst estimates by 40%. Revenue is forecast to grow 8.3% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Annuncio • Apr 28
LB Group Co., Ltd., Annual General Meeting, May 18, 2026 LB Group Co., Ltd., Annual General Meeting, May 18, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Hebei China Annuncio • Mar 31
LB Group Co., Ltd. to Report Q1, 2026 Results on Apr 28, 2026 LB Group Co., Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026 Annuncio • Dec 31
LB Group Co., Ltd. to Report Fiscal Year 2025 Results on Apr 28, 2026 LB Group Co., Ltd. announced that they will report fiscal year 2025 results on Apr 28, 2026 Declared Dividend • Dec 15
Dividend of CN¥0.10 announced Shareholders will receive a dividend of CN¥0.10. Ex-date: 17th December 2025 Payment date: 17th December 2025 Dividend yield will be 3.4%, which is higher than the industry average of 2.6%. Sustainability & Growth Dividend is covered by both earnings (19% earnings payout ratio) and cash flows (69% cash payout ratio). The dividend has increased by an average of 36% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 91% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Major Estimate Revision • Nov 03
Consensus EPS estimates fall by 26% The consensus outlook for earnings per share (EPS) in fiscal year 2025 has deteriorated. 2025 revenue forecast decreased from CN¥28.7b to CN¥27.0b. EPS estimate also fell from CN¥1.22 per share to CN¥0.907 per share. Net income forecast to grow 131% next year vs 52% growth forecast for Chemicals industry in China. Consensus price target broadly unchanged at CN¥21.77. Share price fell 4.6% to CN¥18.26 over the past week. Annuncio • Oct 29
LB Group Co., Ltd. Proposes Cash Dividend (Tax Included) for Third Quarter 2025 LB Group Co., Ltd. at the Extraordinary General Meeting of 2025 held on 12 November 2025, proposed cash dividend (tax included) for third quarter 2025 of CNY 1.00000000 per 10 shares. Reported Earnings • Oct 28
Third quarter 2025 earnings: EPS and revenues miss analyst expectations Third quarter 2025 results: EPS: CN¥0.13 (down from CN¥0.36 in 3Q 2024). Revenue: CN¥6.12b (down 14% from 3Q 2024). Net income: CN¥289.2m (down 66% from 3Q 2024). Profit margin: 4.7% (down from 12% in 3Q 2024). The decrease in margin was driven by lower revenue. Revenue missed analyst estimates by 21%. Earnings per share (EPS) also missed analyst estimates by 56%. Revenue is forecast to grow 10.0% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. Annuncio • Sep 30
LB Group Co., Ltd. to Report Q3, 2025 Results on Oct 28, 2025 LB Group Co., Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025 New Risk • Aug 19
New major risk - Dividend sustainability The dividend is not well covered by earnings and cash flows. Payout ratio: 117% Cash payout ratio: 109% Dividend yield: 5.1% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (18% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Payout ratio: 117% Cash payout ratio: 109% Minor Risk Profit margins are more than 30% lower than last year (6.8% net profit margin). Reported Earnings • Aug 19
Second quarter 2025 earnings: EPS and revenues miss analyst expectations Second quarter 2025 results: EPS: CN¥0.29 (down from CN¥0.31 in 2Q 2024). Revenue: CN¥6.29b (down 3.3% from 2Q 2024). Net income: CN¥699.1m (down 9.2% from 2Q 2024). Profit margin: 11% (in line with 2Q 2024). Revenue missed analyst estimates by 24%. Earnings per share (EPS) also missed analyst estimates by 24%. Revenue is forecast to grow 8.7% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 19% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Annuncio • Jul 02
LB Group Co., Ltd. to Report First Half, 2025 Results on Aug 26, 2025 LB Group Co., Ltd. announced that they will report first half, 2025 results on Aug 26, 2025 Annuncio • Jun 06
LB Group Co., Ltd. Announces First Quarter Distribution, Payable on June 11, 2025 LB Group Co., Ltd. announced that the 2025 1st quarter profit distribution plan to be implemented (A shares): Cash dividend/10 shares (tax included): CNY 5.00. Record date: 10 June 2025. Ex-date: 11 June 2025. Payment date: 11 June 2025. Declared Dividend • Jun 06
Dividend of CN¥0.50 announced Shareholders will receive a dividend of CN¥0.50. Ex-date: 11th June 2025 Payment date: 11th June 2025 Dividend yield will be 4.8%, which is higher than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (38% earnings payout ratio) but not adequately covered by cash flows (97% cash payout ratio). The dividend has increased by an average of 51% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 105% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Annuncio • Apr 25
LB Group Co., Ltd. Proposes Cash Dividend for the First Quarter 2025 LB Group Co., Ltd. proposed first quarter 2025 cash dividend of CNY 5.00000000 per 10 shares (tax included). Reported Earnings • Apr 24
Full year 2024 earnings: EPS and revenues miss analyst expectations Full year 2024 results: EPS: CN¥0.91 (down from CN¥1.38 in FY 2023). Revenue: CN¥27.5b (up 2.9% from FY 2023). Net income: CN¥2.17b (down 32% from FY 2023). Profit margin: 7.9% (down from 12% in FY 2023). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 2.6%. Earnings per share (EPS) also missed analyst estimates by 35%. Revenue is forecast to grow 8.3% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings. Annuncio • Apr 24
LB Group Co., Ltd., Annual General Meeting, May 14, 2025 LB Group Co., Ltd., Annual General Meeting, May 14, 2025, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China Annuncio • Mar 31
LB Group Co., Ltd. to Report Q1, 2025 Results on Apr 24, 2025 LB Group Co., Ltd. announced that they will report Q1, 2025 results on Apr 24, 2025 Annuncio • Dec 31
LB Group Co., Ltd. to Report Fiscal Year 2024 Results on Apr 24, 2025 LB Group Co., Ltd. announced that they will report fiscal year 2024 results on Apr 24, 2025 Annuncio • Nov 15
LB Group Co., Ltd. Approves 3rd Quarter Profit Distribution Plan for 2024 LB Group Co., Ltd. held its 2nd Extraordinary General Meeting of 2024 on 13 November 2024, during were approved 2024 3rd quarter profit distribution plan as Cash dividend/10 shares (tax included): CNY 3.00000000. Annuncio • Oct 30
LB Group Co., Ltd. Proposes Cash Dividend for the Third Quarter of 2024 LB Group Co., Ltd. announced profit distribution proposal for the third quarter of 2024. For the quarter, the company reported Cash dividend/10 shares (tax included) is CNY 3.00000000. Reported Earnings • Oct 29
Third quarter 2024 earnings: EPS and revenues miss analyst expectations Third quarter 2024 results: EPS: CN¥0.36 (down from CN¥0.37 in 3Q 2023). Revenue: CN¥7.09b (up 1.1% from 3Q 2023). Net income: CN¥842.2m (down 4.3% from 3Q 2023). Profit margin: 12% (in line with 3Q 2023). Revenue missed analyst estimates by 10.0%. Earnings per share (EPS) also missed analyst estimates by 3.5%. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 16% per year whereas the company’s share price has fallen by 11% per year. Annuncio • Sep 30
LB Group Co., Ltd. to Report Q3, 2024 Results on Oct 29, 2024 LB Group Co., Ltd. announced that they will report Q3, 2024 results on Oct 29, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to CN¥19.38, the stock trades at a forward P/E ratio of 12x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 21% over the past three years. Reported Earnings • Aug 28
Second quarter 2024 earnings released: EPS: CN¥0.31 (vs CN¥0.29 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.31 (up from CN¥0.29 in 2Q 2023). Revenue: CN¥6.52b (up 3.8% from 2Q 2023). Net income: CN¥770.4m (up 13% from 2Q 2023). Profit margin: 12% (in line with 2Q 2023). Revenue is forecast to grow 9.6% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has fallen by 24% per year, which means it is performing significantly worse than earnings. Annuncio • Jun 29
LB Group Co., Ltd. to Report First Half, 2024 Results on Aug 28, 2024 LB Group Co., Ltd. announced that they will report first half, 2024 results on Aug 28, 2024 Price Target Changed • Jun 19
Price target increased by 9.3% to CN¥25.17 Up from CN¥23.02, the current price target is an average from 8 analysts. New target price is 31% above last closing price of CN¥19.18. Stock is up 16% over the past year. The company is forecast to post earnings per share of CN¥1.64 for next year compared to CN¥1.38 last year. Annuncio • Jun 18
LB Group Co., Ltd. (SZSE:002601) announces an Equity Buyback for CNY 200 million worth of its shares. LB Group Co., Ltd. (SZSE:002601) announces a share repurchase program. Under the program, the company will repurchase up to CNY 200 million worth of its shares. The shares will be purchased at a price not exceeding CNY 32.10 per share. The purpose of the program is to further establish and improve the company's long-term incentive mechanism, attract and retain outstanding talents, safeguard the legitimate rights and interests of all shareholders of the company, and promote the stable and healthy development of the company. The repurchased shares will be used for employee stock ownership plans or equity incentive plans, otherwise will be cancelled if the company fails to transfer them within the time limit stipulated by relevant laws and regulations. The program will be funded from company's own funds. The program will be valid for 12 months. Declared Dividend • May 27
Dividend of CN¥0.60 announced Dividend of CN¥0.60 is the same as last year. Ex-date: 30th May 2024 Payment date: 30th May 2024 Dividend yield will be 4.1%, which is higher than the industry average of 2.6%. Sustainability & Growth Dividend is covered by earnings (19% earnings payout ratio) but not covered by cash flows (177% cash payout ratio). The dividend has increased by an average of 51% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 53% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Annuncio • May 25
Lb Group Co., Ltd. Approves the Cash Dividend of A Shares for the First Quarter of 2024, Payable on 30 May 2024 LB Group Co., Ltd. approved the cash dividend of CNY 6.00000000 per 10 A shares (tax included) for the first quarter of 2024. Record date is 29 May 2024. Ex-date is 30 May 2024. Payment date is 30 May 2024. Annuncio • Apr 24
LB Group Co., Ltd., Annual General Meeting, May 14, 2024 LB Group Co., Ltd., Annual General Meeting, May 14, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Jiaozuo, Henan China Reported Earnings • Apr 24
First quarter 2024 earnings released: EPS: CN¥0.41 (vs CN¥0.24 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.41 (up from CN¥0.24 in 1Q 2023). Revenue: CN¥7.29b (up 4.6% from 1Q 2023). Net income: CN¥951.1m (up 64% from 1Q 2023). Profit margin: 13% (up from 8.3% in 1Q 2023). Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 13% per year whereas the company’s share price has fallen by 16% per year. Annuncio • Mar 30
LB Group Co., Ltd. to Report Q1, 2024 Results on Apr 24, 2024 LB Group Co., Ltd. announced that they will report Q1, 2024 results on Apr 24, 2024 Annuncio • Dec 30
LB Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 24, 2024 LB Group Co., Ltd. announced that they will report fiscal year 2023 results on Apr 24, 2024 Annuncio • Nov 02
LB Group Co., Ltd. Implements 3rd Quarter Profit Distribution Plan for 2023, payable on 08 November 2023 LB Group Co., Ltd. announced 2023 3rd quarter profit distribution plan to be implemented (A shares) Cash dividend/10 shares (tax included): CNY 3.00000000. Record date: 07 November 2023, Ex-date: 08 November 2023, Payment date: 08 November 2023. Annuncio • Nov 01
LB Group Co., Ltd. Approves Cash Dividend for the Third Quarter of 2023 LB Group Co., Ltd. in its 7th Extraordinary General Meeting of 2023 on 30 October 2023 approved the cash dividend per 10 shares (tax included) of CNY 3.00000000 for the third quarter of 2023. Annuncio • Oct 17
LB Group Co., Ltd. Proposes Quarterly Cash Dividend for the Third Quarter of 2023 LB Group Co., Ltd. proposed quarterly cash dividend per 10 shares (tax included) of CNY 3.00000000 for the third quarter of 2023. Reported Earnings • Oct 14
Third quarter 2023 earnings: EPS and revenues exceed analyst expectations Third quarter 2023 results: EPS: CN¥0.37 (down from CN¥0.40 in 3Q 2022). Revenue: CN¥7.04b (up 25% from 3Q 2022). Net income: CN¥880.0m (down 3.0% from 3Q 2022). Profit margin: 13% (down from 16% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 14%. Earnings per share (EPS) also surpassed analyst estimates by 7.5%. Revenue is forecast to grow 17% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has fallen by 11% per year, which means it is performing significantly worse than earnings. Reported Earnings • Aug 26
Second quarter 2023 earnings: EPS and revenues miss analyst expectations Second quarter 2023 results: EPS: CN¥0.29 (down from CN¥0.57 in 2Q 2022). Revenue: CN¥6.29b (flat on 2Q 2022). Net income: CN¥682.6m (down 43% from 2Q 2022). Profit margin: 11% (down from 19% in 2Q 2022). Revenue missed analyst estimates by 17%. Earnings per share (EPS) also missed analyst estimates by 36%. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 3% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Annuncio • May 24
LB Group Co., Ltd. Approves Cash Dividend on A Shares for the First Quarter of 2023, Payable on May 29, 2023 LB Group Co., Ltd. approved Cash dividend/10 shares (tax included) of CNY 6.00000000 on A shares for the first quarter of 2023, payable on May 29, 2023. Record date: May 26, 2023; and Ex-date: May 29, 2023. Major Estimate Revision • May 09
Consensus EPS estimates fall by 11% The consensus outlook for fiscal year 2023 has been updated. 2023 EPS estimate fell from CN¥2.06 to CN¥1.83 per share. Revenue forecast steady at CN¥30.8b. Net income forecast to grow 64% next year vs 54% growth forecast for Chemicals industry in China. Consensus price target down from CN¥24.79 to CN¥23.95. Share price was steady at CN¥17.07 over the past week. Reported Earnings • Apr 29
First quarter 2023 earnings released: EPS: CN¥0.24 (vs CN¥0.45 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.24 (down from CN¥0.45 in 1Q 2022). Revenue: CN¥6.98b (up 15% from 1Q 2022). Net income: CN¥579.4m (down 46% from 1Q 2022). Profit margin: 8.3% (down from 18% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 21% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
High number of new directors There are 5 new directors who have joined the board in the last 3 years. CFO, Financial Manager & Non-Independent Director Qing Fei Shen was the last director to join the board, commencing their role in 2020. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Annuncio • Nov 11
Lb Group Co., Ltd. Approves Profit Distribution for the Third Quarter of 2022 LB Group Co., Ltd. announced at the EGM held on November 9, 2022 that the company approved Cash dividend/10 shares (tax included) of CNY2.00000000 for the third quarter of 2022. Annuncio • Oct 26
LB Group Co., Ltd. Proposes Profit Distribution for the Third Quarter of 2022 LB Group Co., Ltd. announced on 25 October 2022 the profit distribution proposal for the third quarter of 2022 as follows: cash dividend (tax included) of CNY 2.00000000 per ten shares. Reported Earnings • Oct 25
Third quarter 2022 earnings released: EPS: CN¥0.40 (vs CN¥0.76 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.40 (down from CN¥0.76 in 3Q 2021). Revenue: CN¥5.66b (up 4.3% from 3Q 2021). Net income: CN¥907.0m (down 35% from 3Q 2021). Profit margin: 16% (down from 26% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Buying Opportunity • Oct 25
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 26%. The fair value is estimated to be CN¥18.90, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 22%. Revenue is forecast to grow by 43% in 2 years. Earnings is forecast to grow by 27% in the next 2 years. Buying Opportunity • Sep 16
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 20%. The fair value is estimated to be CN¥20.89, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 29% over the last 3 years. Earnings per share has grown by 22%. Revenue is forecast to grow by 42% in 2 years. Earnings is forecast to grow by 32% in the next 2 years. Reported Earnings • Aug 23
Second quarter 2022 earnings released: EPS: CN¥0.57 (vs CN¥0.60 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.57 (down from CN¥0.60 in 2Q 2021). Revenue: CN¥6.36b (up 22% from 2Q 2021). Net income: CN¥1.20b (down 12% from 2Q 2021). Profit margin: 19% (down from 26% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 23%, compared to a 41% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Price Target Changed • Aug 22
Price target decreased to CN¥26.25 Down from CN¥28.73, the current price target is an average from 6 analysts. New target price is 39% above last closing price of CN¥18.84. Stock is down 44% over the past year. The company is forecast to post earnings per share of CN¥2.04 for next year compared to CN¥2.12 last year. Board Change • May 26
High number of new directors There are 5 new directors who have joined the board in the last 3 years. CFO, Financial Manager & Non-Independent Director Qing Fei Shen was the last director to join the board, commencing their role in 2020. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Annuncio • May 12
LB Group Co., Ltd. Announces of Cash Dividend on A Shares for the First Quarter of 2022, Payable on 17 May 2021 LB Group Co., Ltd. announced plan to be implemented of Cash dividend/10 shares CNY 10.00000000 (tax included) A shares for the first quarter of 2022. Record date on 13 May 2022, Ex-date on 16 May 2022 and Payment date on 16 May 2022. Price Target Changed • Apr 27
Price target decreased to CN¥41.29 Down from CN¥44.53, the current price target is an average from 8 analysts. New target price is 135% above last closing price of CN¥17.59. Stock is down 50% over the past year. The company is forecast to post earnings per share of CN¥2.21 for next year compared to CN¥2.12 last year. Annuncio • Apr 21
Lomon Billions Group Co., Ltd. Announces Profit Distribution Proposal for the first quarter of 2022 Lomon Billions Group Co., Ltd. announced on 20 April 2022 the profit distribution proposal for 2022 as follows: Cash dividend of CNY 10.00000000 per 10 shares (tax included). Major Estimate Revision • Apr 19
Consensus forecasts updated The consensus outlook for 2022 has been updated. 2022 revenue forecast increased from CN¥23.2b to CN¥24.6b. EPS estimate fell from CN¥2.47 to CN¥2.19 per share. Net income forecast to grow 11% next year vs 41% growth forecast for Chemicals industry in China. Consensus price target down from CN¥44.53 to CN¥41.29. Share price fell 11% to CN¥20.84 over the past week. Price Target Changed • Apr 18
Price target decreased to CN¥41.29 Down from CN¥44.53, the current price target is an average from 8 analysts. New target price is 98% above last closing price of CN¥20.84. Stock is down 30% over the past year. The company is forecast to post earnings per share of CN¥2.19 for next year compared to CN¥2.12 last year. Annuncio • Apr 16
LB Group Co., Ltd., Annual General Meeting, May 05, 2022 LB Group Co., Ltd., Annual General Meeting, May 05, 2022, at 14:30 China Standard Time. Agenda: To consider 2021 work report of the board of directors; to consider 2021 work report of the supervisory committee; to consider 2021 annual report and its summary; to consider 2021 annual accounts; and to consider other matters. Reported Earnings • Apr 13
Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2021 results: EPS: CN¥2.12 (up from CN¥1.13 in FY 2020). Revenue: CN¥20.6b (up 46% from FY 2020). Net income: CN¥4.68b (up 104% from FY 2020). Profit margin: 23% (up from 16% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 6.5%. Earnings per share (EPS) missed analyst estimates by 4.2%. Over the next year, revenue is forecast to grow 12%, compared to a 48% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Price Target Changed • Nov 16
Price target increased to CN¥46.26 Up from CN¥43.16, the current price target is an average from 9 analysts. New target price is 74% above last closing price of CN¥26.64. Stock is down 15% over the past year. The company is forecast to post earnings per share of CN¥2.22 for next year compared to CN¥1.13 last year. Reported Earnings • Oct 26
Third quarter 2021 earnings released: EPS CN¥0.76 (vs CN¥0.32 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥5.47b (up 53% from 3Q 2020). Net income: CN¥1.40b (up 113% from 3Q 2020). Profit margin: 26% (up from 18% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment deteriorated over the past week After last week's 19% share price decline to CN¥28.24, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 148% over the past three years. Valuation Update With 7 Day Price Move • Aug 31
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥37.50, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 231% over the past three years. Reported Earnings • Aug 24
Second quarter 2021 earnings released: EPS CN¥0.60 (vs CN¥0.20 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥5.22b (up 98% from 2Q 2020). Net income: CN¥1.37b (up 250% from 2Q 2020). Profit margin: 26% (up from 15% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Aug 13
Investor sentiment improved over the past week After last week's 21% share price gain to CN¥36.42, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 20x in the Chemicals industry in China. Total returns to shareholders of 228% over the past three years. Annuncio • May 11
Lomon Billions Group Co., Ltd. Announces Plan to Be Implemented of Cash Dividend on A Shares, Payable on 17 May 2021 Lomon Billions Group Co., Ltd. announced plan to be implemented of Cash dividend/10 shares CNY 9.00000000 (tax included) A shares for the first quarter of 2021. Record date on 14 May 2021, Ex-date on 17 May 2021 and Payment date on 17 May 2021. Reported Earnings • Apr 17
Full year 2020 earnings released: EPS CN¥1.13 (vs CN¥1.29 in FY 2019) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥14.2b (up 25% from FY 2019). Net income: CN¥2.29b (down 12% from FY 2019). Profit margin: 16% (down from 23% in FY 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Mar 23
Investor sentiment deteriorated over the past week After last week's 18% share price decline to CN¥28.00, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 23x in the Chemicals industry in China. Total returns to shareholders of 84% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at CN¥13.48 per share. Annuncio • Mar 08
Lomon Billions Group Co., Ltd. to Report Fiscal Year 2020 Results on Apr 20, 2021 Lomon Billions Group Co., Ltd. announced that they will report fiscal year 2020 results on Apr 20, 2021 Valuation Update With 7 Day Price Move • Mar 08
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥35.11, the stock is trading at a trailing P/E ratio of 29x, down from the previous P/E ratio of 34.4x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 126%. Valuation Update With 7 Day Price Move • Feb 12
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥48.48, the stock is trading at a trailing P/E ratio of 40x, up from the previous P/E ratio of 33.5x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 236%. Is New 90 Day High Low • Feb 10
New 90-day high: CN¥48.48 The company is up 62% from its price of CN¥29.90 on 12 November 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 21% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥13.70 per share. Is New 90 Day High Low • Jan 21
New 90-day high: CN¥41.43 The company is up 67% from its price of CN¥24.76 on 23 October 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥13.66 per share. Price Target Changed • Jan 12
Price target raised to CN¥34.74 Up from CN¥30.98, the current price target is an average from 7 analysts. The new target price is 10.0% below the current share price of CN¥38.59. As of last close, the stock is up 125% over the past year. Valuation Update With 7 Day Price Move • Jan 07
Investor sentiment improved over the past week After last week's 19% share price gain to CN¥36.76, the stock is trading at a trailing P/E ratio of 30.3x, up from the previous P/E ratio of 25.4x. This compares to an average P/E of 36x in the Chemicals industry in China. Total returns to shareholders over the past three years are 156%. Is New 90 Day High Low • Jan 05
New 90-day high: CN¥35.12 The company is up 51% from its price of CN¥23.29 on 30 September 2020. The Chinese market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 16% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥13.79 per share. Price Target Changed • Dec 09
Price target raised to CN¥30.98 Up from CN¥28.80, the current price target is an average from 7 analysts. The new target price is 5.4% below the current share price of CN¥32.75. As of last close, the stock is up 149% over the past year. Valuation Update With 7 Day Price Move • Nov 13
Market bids up stock over the past week After last week's 16% share price gain to CN¥30.06, the stock is trading at a trailing P/E ratio of 24.8x, up from the previous P/E ratio of 21.4x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 141%. Valuation Update With 7 Day Price Move • Nov 11
Market bids up stock over the past week After last week's 17% share price gain to CN¥29.30, the stock is trading at a trailing P/E ratio of 24.2x, up from the previous P/E ratio of 20.6x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past three years are 126%. Is New 90 Day High Low • Nov 11
New 90-day high: CN¥29.30 The company is up 26% from its price of CN¥23.25 on 13 August 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 5.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥11.72 per share. Reported Earnings • Nov 03
Third quarter 2020 earnings released: EPS CN¥0.32 The company reported a soft third quarter result with weaker earnings and profit margins, although revenues were improved. Third quarter 2020 results: Revenue: CN¥3.61b (up 24% from 3Q 2019). Net income: CN¥656.8m (down 18% from 3Q 2019). Profit margin: 18% (down from 27% in 3Q 2019). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 15% per year, which means it is tracking significantly ahead of earnings growth. Analyst Estimate Surprise Post Earnings • Nov 03
Revenue and earnings miss expectations Revenue missed analyst estimates by 1.7%. Earnings per share (EPS) also missed analyst estimates by 20%. Over the next year, revenue is forecast to grow 19%, compared to a 49% growth forecast for the Chemicals industry in China. Valuation Update With 7 Day Price Move • Oct 13
Market bids up stock over the past week After last week's 21% share price gain to CN¥28.25, the stock is trading at a trailing P/E ratio of 21.9x, up from the previous P/E ratio of 18.1x. This compares to an average P/E of 40x in the Chemicals industry in China. Total returns to shareholders over the past three years are 92%. Price Target Changed • Oct 13
Price target raised to CN¥27.69 Up from CN¥25.49, the current price target is an average from 8 analysts. The new target price is close to the current share price of CN¥28.25. As of last close, the stock is up 134% over the past year. Is New 90 Day High Low • Oct 12
New 90-day high: CN¥26.61 The company is up 12% from its price of CN¥23.83 on 14 July 2020. The Chinese market is down 6.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥10.92 per share.